<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02060461</url>
  </required_header>
  <id_info>
    <org_study_id>11-744</org_study_id>
    <nct_id>NCT02060461</nct_id>
  </id_info>
  <brief_title>LASIK Flap Thickness and Visual Outcomes Using the WaveLight FS200 Femtosecond Laser</brief_title>
  <acronym>FS200</acronym>
  <official_title>LASIK Flap Thickness and Visual Outcomes Using the WaveLight FS200 Femtosecond Laser: 3 Months Follow-up of Initial US Clinical Series</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the visual outcome, accuracy, predictability and
      complications of LASIK flap creation using the Alcon Wavelight FS200 Femtosecond laser and
      compare these results to those obtained using current IntraLase FS60 Femtosecond laser. The
      primary outcome to be evaluated is the flap thickness accuracy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laser in situ keratomileusis (LASIK) is a method for treating myopia, hyperopia and
      astigmatism. In LASIK, the cornea is reshaped to focus images more clearly on the retina
      without the aid of glasses or contact lenses. LASIK involves two steps: creation of a corneal
      flap, which can be performed by a mechanical microkeratome or a femtosecond laser, and
      reshaping of the cornea by another laser, an excimer laser.

      The accuracy of the LASIK flap thickness is a key safety consideration to reduce the
      likelihood of complications following LASIK. Femtosecond laser technology has significantly
      improved the predictability of LASIK flap dimensions while supporting similar visual acuity
      results.

      The Alcon FS200 femtosecond laser is approved for human use by the United States Food and
      Drug Administration and was recently released in the US market. This study will directly
      compare outcomes of LASIK performed with this newer laser to those performed with the AMO
      IntraLase femtosecond laser.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Contralateral eye study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of LASIK Flap Thickness</measure>
    <time_frame>3 months</time_frame>
    <description>Central LASIK flap thickness for each femtosecond laser. Each treatment was set for a 110 micrometer thick flap.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>FS200 femtosecond laser LASIK</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LASIK flap created with an FS200 femtosecond laser system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IntraLase femtosecond laser LASIK</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LASIK flap created with an IntraLase femtosecond laser system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FS200 femtosecond laser LASIK</intervention_name>
    <arm_group_label>FS200 femtosecond laser LASIK</arm_group_label>
    <other_name>Alcon FS200 femtosecond laser</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IntraLase femtosecond laser LASIK</intervention_name>
    <arm_group_label>IntraLase femtosecond laser LASIK</arm_group_label>
    <other_name>AMO IntraLase femtosecond laser</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with ametropia (Spherical, spherocylindrical, presbyopic) suitable for
             treatment by LASIK, including different target refractions (Plano or Monovision).

        Exclusion Criteria:

          -  Patients unsuitable for LASIK procedure because of an estimated residual stromal bed &lt;
             300 microns after calculation of the ablation (Corneal thickness - flap thickness -
             simulated stromal ablation for the desired correction).

          -  Patients unsuitable for LASIK due suspicious topography for ectasia, form frust
             keratoconus or unstable ( more than 0.50 diopter change in sphere or cylinder in the
             last year) refraction.

          -  Patients with amblyopia or any eye disease that might limit the visual recovery.

          -  Patients younger than 18 years old.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William J Dupps, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Rocha KM, Krueger RR. Spectral-domain optical coherence tomography epithelial and flap thickness mapping in femtosecond laser-assisted in situ keratomileusis. Am J Ophthalmol. 2014 Aug;158(2):293-301.e1. doi: 10.1016/j.ajo.2014.04.012. Epub 2014 Apr 30.</citation>
    <PMID>24792107</PMID>
  </results_reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 16, 2013</study_first_submitted>
  <study_first_submitted_qc>February 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2014</study_first_posted>
  <results_first_submitted>January 23, 2017</results_first_submitted>
  <results_first_submitted_qc>February 22, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">March 23, 2018</results_first_posted>
  <last_update_submitted>February 22, 2018</last_update_submitted>
  <last_update_submitted_qc>February 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Comparison of Femtosecond Lasers in LASIK</title>
          <description>Outcomes of femtosecond-assisted LASIK will be compared between yes in subjects using the FS200 femtosecond laser in one eye and the IntraLase in the other.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Comparison of Femtosecond Lasers in LASIK</title>
          <description>Outcomes of femtosecond-assisted LASIK will be compared between yes in subjects using the FS200 laser in one eye and the IntraLase in the other.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.5" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of LASIK Flap Thickness</title>
        <description>Central LASIK flap thickness for each femtosecond laser. Each treatment was set for a 110 micrometer thick flap.</description>
        <time_frame>3 months</time_frame>
        <population>Contralateral eyes</population>
        <group_list>
          <group group_id="O1">
            <title>FS200 Femtosecond Laser LASIK</title>
            <description>FS200 laser used to create LASIK flap</description>
          </group>
          <group group_id="O2">
            <title>IntraLase Femtosecond Laser LASIK</title>
            <description>IntraLase femtosecond laser used to create LASIK flap</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of LASIK Flap Thickness</title>
          <description>Central LASIK flap thickness for each femtosecond laser. Each treatment was set for a 110 micrometer thick flap.</description>
          <population>Contralateral eyes</population>
          <units>micrometers</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105.8" spread="10.3"/>
                    <measurement group_id="O2" value="112.9" spread="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Paired Students t-test of FS200 and IntraLase intraoperative flap thickness measurements obtained by ultrasound pachymetry</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>.003</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>FS200 Femtosecond Laser LASIK</title>
          <description>FS200 femtosecond laser used to create LASIK flap</description>
        </group>
        <group group_id="E2">
          <title>IntraLase Femotsecond Laser LASIK</title>
          <description>IntraLase femtosecond laser used to create LASIK flap</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>William J Dupps, Jr, MD, PhD</name_or_title>
      <organization>Cleveland Clinic</organization>
      <phone>216-444-8396</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

